← Back to headlines
Morgan Stanley Downgrades Smith & Nephew on Guidance Concerns
Investment bank Morgan Stanley has lowered its stock rating for medical device maker Smith & Nephew, citing worries over the company's future earnings guidance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Panama Canal weighs deeper transit cuts as El Niño drought persists
53m ago
Jaguar Land Rover to cut 4,000 jobs over two years
1h ago
Oil Prices Surge Toward $100 Amid Escalating U.S.-Iran Tensions and Supply Fears
1h ago
EverBank and WaFd Announce $3.9 Billion Merger to Form $75 Billion Institution
1h ago